Cough, cold and allergy (hay fever) remedies is expected to be largely unaffected by COVID-19, with similar healthy double-digit value growth as 2019. However, part of this growth in 2020 is driven by inflation as a result of the economic effect of COVID-19, which has led to price rises. Though the product area is expected to register similar growth to 2019, consumer behaviour is expected to change slightly. Unlike 2019, where medicated confectionery recorded the highest value growth, cough…

Panic and fear caused by the outbreak of COVID-19 has provoked Moroccan consumers to stockpile many products in cough, cold and allergy (hay fever) remedies. In most cases, consumer decision making was based on future precaution rather than specific need, with customers preparing for extended periods of lockdown as future restrictions seemed uncertain. Many consumers, for example, stockpiled nasal sprays and decongestants, which are both expected to see considerable value and volume growth…

In 2020, cough, cold and allergy (hay fever) remedies is expected to see stronger current value growth than in any other year of the review period. The stronger growth rate is because consumers have been trying to protect themselves from COVID-19 by avoiding going to doctors’ clinics or hospitals, where they fear they are more likely to contract the virus. This consumer behaviour is expected to continue for the rest of the year, since the country has not yet been successful in controlling…

Overall consumer health is not expected to see a significant difference in its growth rate in 2020 compared with the previous year, with just a marginally higher current value increase. However, the emergence of the COVID-19 virus in the country at the beginning of the year had different impacts on different consumer health categories. For instance, there was a dramatic increase in demand for dietary supplements, systemic analgesics and cough, cold and allergy (hay fever) remedies in the…

Consumer health is expected to see slower current value growth in 2020 than was seen in the previous year. One of the factors dictating growth in this year is expected to be COVID-19. As news about the virus emerged in the country, consumers began panic-buying at the beginning of March, stockpiling certain consumer health products, such as analgesics, cough, cold and allergy (hay fever) remedies, immunity-boosting vitamins and dietary supplements, for fear of shortages. However, this was…

One major impact on consumer health in Tunisia, in light of COVID-19, is the negative affect on consumer spending power, with economists believing that purchasing power declined 30% in Q2 2020. Therefore, Tunisians are expected to become increasingly price-sensitive due to economic conditions in the country and the impacts from COVID-19. However, on a positive note, the trend for self-medication continues to grow in the country, which supports most sub-categories in consumer health. This…

2020 is not expected to be a good year for consumer health in Thailand, with a strong current value decline expected, after seeing strong growth in all other years of the review period. At the beginning of the year the country was already suffering from a soft economic environment, as well as other factors, including droughts, high household debt, unemployment and a slowdown in tourism. Technological disruption was also leading to an escalating number of job losses and unemployment,…

COVID-19 will have a negative impact on demand for consumer health in 2020, with the rate of growth in value sales slowing. In analgesics, the negative impact of COVID-19 on disposable incomes means that consumers are now less likely to purchase them as a precautionary measure. Demand growth for cough, cold and allergy (hay fever) remedies has been undermined by the fact that COVID-19 lockdowns led to a decrease in the incidence of colds and flu, particularly when compared to the previous…

Consumer health in Slovakia is expected to show considerable resilience in response to the COVID-19 pandemic. Despite troubling economic circumstances, many consumers saw consumer health products as indispensable and continued to buy them despite decreasing incomes. Initial stockpiling in March did cause some product shortages, particularly in cough, cold and allergy (hay fever) remedies. Medication like acetaminophen and ibuprofen were particularly affected as people looked to pre-empt…

There were no reports of panic buying or product shortages in consumer health during the early stages of the COVID-19, and the pandemic will have no more than a slight negative effect on the rate of value sales growth during 2020. Demand for analgesics continues to be buoyed by a growing preference for self-medication for minor health problems, with Serbian consumers increasingly likely to seek solutions on their own – or with the help of a pharmacist – when suffering from minor or moderate…

Consumer health is expected to see lower current value growth in 2020 than was seen the previous year, largely as a result of COVID-19. The hardest hit categories in 2020 are likely to be sports nutrition and weight management. The demand for these products was significantly dampened due to the introduction of lockdown restrictions, which saw the closure of sports facilities and gyms. Equally, the negative impact of COVID-19 on the economic situation has led to increased unemployment in…

COVID-19 will boost demand for consumer health products in 2020, with slightly higher current value growth expected as a result. As news about the virus emerged in the Peru, with the first case hitting the country in March 2020, consumers began panic-buying, causing sales of a range of products related to the virus to increase. The demand for winter products, such as cold and flu medicines, spiked much sooner than usual, as did prescription products for chronic diseases, with consumers…

The outbreak of COVID-19 is not set to increase growth in 2020, with value growth of 3% predicted, compared to value growth of 4% recorded in 2019. Unlike other countries within Western Europe, there was not a high level of stockpiling reported for consumer health products in Norway. However, adult acetaminophen was one area which recorded a spike in sales in Q1 and Q2, due to the negative press surrounding ibuprofen, and adverse effects the product could have on those suffering from…

Overall, COVID-19 is not expected to have a major impact on consumer health in Nigeria and it expected that current value growth in 2020, will be similar to 2019 and will continue to register double-digit growth, as it has over the review period. However, drilling down within the product area, there are certain products that will benefit from concerns around COVID-19, and other products that will register lower value growth.

ALSO READ: …

The COVID-19 pandemic is expected to have a considerable impact on consumer health in Morocco in 2020 as consumer purchasing adapts according to the drastic changes in consumer lifestyles, habits, and behaviours. As consumers react to the uncertainty of the future of the pandemic, with claims that the pandemic could continue for two or more years, many consumers have become more proactive than reactive in their buying habits, initially stockpiling early in the 2020 and then ensuring…

Overall consumer health is expected to see a slightly slower current value growth rate in 2020 than seen in any other year of the review period. Although this is due to the COVID-19 outbreak in the country, categories are being impacted in very different ways. Consumer behaviour and spending on consumer health products have changed significantly in some categories due to the pandemic. For instance, vitamins is expected to see a strong spike in demand in 2020. Consumers are increasing their…

Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than volume increases. Egypt is still recovering from the severe devaluation of the Egyptian pound against major global currencies in late 2017, which forced…

COVID-19 has accelerated underlying decline in charge cards in 2020. These are by a distance the least popular form of financial cards in circulation in Sweden in 2020, with demand for them limited by their impracticality. Whereas credit cards enjoy more or less universal acceptance by merchants, charge cards f=do not, and the category has been undermined over the forecast period by a shrinking amount of provision. Diners Club Nordic withdrew from the region at the end of May 2019, and…

As seen throughout the review period, analgesics is expected to maintain double-digit current value growth in 2020, with a slightly higher growth rate than seen in the previous few years. The demand for analgesics increased significantly in the first three months of 2020, mainly due to the COVID-19 pandemic. This dramatic increase was because people believed it was necessary to keep analgesics at home to reduce the fever from COVID-19 in case the pandemic could not be controlled and they…

During the quarantine in March 2020, many Ukrainians rushed to buy analgesics fearing possible shortages during the COVID-19 outbreak. Among the most popular ones were adult acetaminophen, paediatric ibuprofen and adult combination products - analgesics, with the brands Paracetamol, Nurofen and Spasmalgon respectively standing out as consumer favourites. Such products are the most well-known by consumers and leading brand manufacturers Nurofen and Spasmalgon further attracted consumers with…